• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Nutraceuticals
    • Markets
    • Health
    • Jobs
    • Events
    • Buyers' Guide
    • Showcases
    • More
  • Magazine
  • News
  • Exclusives
  • Nutraceuticals
  • Markets
  • Health
  • Jobs
  • Events
  • Buyers' Guide
  • Showcases
  • Current & Past Issues
    Features
    Columns
    Editorials
    Digital Edition
    Subscribe Now
    Advertise Now
    eNewsletter
    Editorial Guidelines
    Top Features
    A Kingdom of Their Own: Fungi Shine While Mushrooms Emerge as Market Stars

    Functional Beverage Market Shakes Things Up with Formulation Breakthroughs

    The Pet Health Boom: Supplement Growth Set to Build on Rapid Expansion

    (Re)Open for Business: China’s Strong Demand for Natural Products Spells Opportunity for U.S. Brands

    Review Finds No Causative Connection Between Dietary Supplements and Eating Disorders
    Breaking News
    Certifications, Approvals and Patents
    Exclusives
    Industry & Market News
    People
    Products
    Regulatory
    Glossary
    Research
    Supplier News
    Supplier Insights
    Live From Shows
    Top News
    SmartyPants Vitamins Launches New Line of Gelatin-Free Multivitamin Gummies

    Flavanol Deficiency Linked to Age-Related Memory Decline: COSMOS-Web Study

    AHPA to Attend CITES Plants Committee Meeting in Geneva

    NY General Assembly Passes Bill to Restrict Sales of Weight Loss Supplements

    Stefan Pasiakos, PhD, Selected to Lead NIH Office of Dietary Supplements
    Exclusives
    Blogs & Guest Articles
    Health E-Insights
    Area Code 420
    eBook
    Antioxidants
    Dairy-Based Ingredients
    Enzymes
    Fatty Acids
    Fiber & Carbohydrates
    Green Foods
    Herbs & Botanicals
    Marine Nutraceuticals
    Minerals
    Omega 3s
    Probiotics & Prebiotics
    Proteins, Peptides, Amino Acids
    Sweeteners
    Vitamins

    SmartyPants Vitamins Launches New Line of Gelatin-Free Multivitamin Gummies

    Flavanol Deficiency Linked to Age-Related Memory Decline: COSMOS-Web Study

    AHPA to Attend CITES Plants Committee Meeting in Geneva

    Shroom(rise) Kingdom

    Improving Taste and Mouthfeel of Plant-Based Protein Formulations
    Consumer Trends
    Contract Manufacturing
    Cosmeceuticals / Nutricosmetics
    Delivery & Dosage Technologies
    Dietary Supplements
    Flavors & Colors
    Functional Foods & Beverages
    Healthcare Trends
    Medical Nutrition
    Mergers & Acquisitions
    Natural/Organic
    Nutrition Bars
    Packaging
    Pet Nutraceuticals
    Quality & Safety
    Regulations
    Research
    Testing
    World Markets

    SmartyPants Vitamins Launches New Line of Gelatin-Free Multivitamin Gummies

    Flavanol Deficiency Linked to Age-Related Memory Decline: COSMOS-Web Study

    AHPA to Attend CITES Plants Committee Meeting in Geneva

    NY General Assembly Passes Bill to Restrict Sales of Weight Loss Supplements

    Shroom(rise) Kingdom
    Bone & Joint Health
    Cancer Risk
    Cardiovascular Health
    Cognitive Function
    Diabetes & Blood Sugar Management
    Digestive Health
    Energy
    Eye Health
    Healthy Aging
    Immune Function
    Infant & Children's Health
    Inflammation
    Men's Health
    Mood Health & Sleep
    Oral Health
    Sexual & Reproductive Health
    Skin Health
    Sports Nutrition
    Weight Management/Weight Loss
    Women's Health

    Flavanol Deficiency Linked to Age-Related Memory Decline: COSMOS-Web Study

    NY General Assembly Passes Bill to Restrict Sales of Weight Loss Supplements

    Functional Beverage Market Shakes Things Up with Formulation Breakthroughs

    A Kingdom of Their Own: Fungi Shine While Mushrooms Emerge as Market Stars

    ‘Uniquely Unbound’: Releasing the Potential, and Genius, of Walnuts
    Industry Events
    Live From Show Events
    Webinars
    All Companies
    Categories
    Trade Associations
    Company Capabilities
    International Buyers Guide Companies
    Applied Food Sciences, Inc.

    Xsto Solutions

    Bioenergy Life Science, Inc. (BLS)

    Nutrition21, LLC

    KLK OLEO
    Companies
    Product Releases
    News Releases
    Literature / Brochures
    White Papers
    Jobs
    VIdeos
    Services
    Add New Company
    International Buyers Guide Companies
    Applied Food Sciences, Inc.

    Xsto Solutions

    Bioenergy Life Science, Inc. (BLS)

    Nutrition21, LLC

    KLK OLEO
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • All Companies
      • Categories
      • Trade Associations
      • Company Capabilities
    • Nutraceuticals
      • Antioxidants
      • Dairy-Based Ingredients
      • Enzymes
      • Fatty Acids
      • Fiber & Carbohydrates
      • Green Foods
      • Herbs & Botanicals
      • Marine Nutraceuticals
      • Minerals
      • Omega 3s
      • Probiotics & Prebiotics
      • Proteins, Peptides, Amino Acids
      • Sweeteners
      • Vitamins
    • Markets
      • Consumer Trends
      • Contract Manufacturing
      • Cosmeceuticals / Nutricosmetics
      • Delivery & Dosage Technologies
      • Dietary Supplements
      • Flavors & Colors
      • Functional Foods & Beverages
      • Healthcare Trends
      • Medical Nutrition
      • Mergers & Acquisitions
      • Natural/Organic
      • Nutrition Bars
      • Packaging
      • Pet Nutraceuticals
      • Quality & Safety
      • Regulations
      • Research
      • Testing
      • World Markets
    • Health
      • Bone & Joint Health
      • Cancer Risk
      • Cardiovascular Health
      • Cognitive Function
      • Diabetes & Blood Sugar Management
      • Digestive Health
      • Energy
      • Eye Health
      • Healthy Aging
      • Immune Function
      • Infant & Children's Health
      • Inflammation
      • Men's Health
      • Mood Health & Sleep
      • Oral Health
      • Sexual & Reproductive Health
      • Skin Health
      • Sports Nutrition
      • Weight Management/Weight Loss
      • Women's Health
    • Online Exclusives
    • Webinars
    • Slideshows
    • Blogs & Guest Articles
    • Health E-Insights
    • Videos
    • Podcasts
    • Infographics
    • eBook
    • Whitepapers
    • Research
      • TrendSense
      • Monograph Center
      • White Papers
      • Research News
    • Jobs
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Supplier Showcases
      • Companies
      • Product Releases
      • News Releases
      • Literature / Brochures
      • White Papers
      • Jobs
      • VIdeos
      • Services
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Features

    Silent Inflammation

    The root cause of many of the major chronic diseases is inflammation and there are many nutraceuticals that can play a role in curbing this risk factor.

    Dr. Barry Sears05.01.05
    What if there was a condition that threatened to destroy the entire U.S. healthcare system in a very short time? Every politician would be making speeches about it. There would be a mobilization of the entire medical establishment to combat it. The media would constantly report on the progress to eradicate it. It would even be the central topic discussed on daytime TV by Oprah and Dr. Phil. Unfortunately, such a condition does exist and no one seems concerned about it. This condition is "silent" inflammation.

    What is Silent Inflammation?
    Inflammation is critical for our survival against a hostile world. Without a strong inflammatory response we would be "sitting ducks" for microbial attack or injuries that never healed. However, there are two different types of inflammation. One type is "classical" inflammation, which is usually associated with pain. This type of inflammation can also result from the continuing warfare of an overactive immune system that is constantly turned on so that the body attacks itself. This is precisely what happens in the case of the autoimmune diseases like rheumatoid arthritis or irritable bowel syndrome.

    Silent inflammation, on the other hand, is different from classical inflammation in that it is below the threshold of perceived pain. As a result, no action is taken to stop it, and so it lingers for years, if not decades, causing continued insults on the heart, the immune system and the brain. These continued insults often result in heart disease, cancer and Alzheimer's.

    In many ways, silent inflammation can be considered "silent pain" in that the immune system continues to attack at the cellular level but without the perception of pain. Like free radicals, the existence of silent inflammation is not a disease, only an indication that potential medical problems lay ahead.

    All inflammation is ultimately driven by a group of hormones known as eicosanoids. These hormones are derived from long-chain essential fatty acids and can be altered by dietary interventions. Although the search for anti-inflammatory medications to shut down the generation of inflammatory pain has been the goal of medicine since recorded history, very little progress has been made in measuring the extent of other types of inflammation other than asking a patient how much something hurts.

    Thus, for years it was impossible to even discuss silent inflammation, let alone how to reverse it, until suitable clinical markers were established. The first of those markers was high sensitivity C-reactive protein (hs-CRP). This is a relatively non-specific marker of chronic low-level inflammation since it can dramatically increase with any type of infection. However, an increase in hs-CRP only indicates that low-level inflammation has already started. The actual silent inflammation occurs well before the appearance of C-reactive protein. Thus, it is critical to stop silent inflammation at the cellular level.

    To measure this type of silent inflammation, a new, much more powerful clinical marker of silent inflammation has been developed. This includes the ratio of long-chain omega 6 fatty acid arachidonic acid (AA) to the long-chain omega 3 fatty acid eicosapentaenoic acid (EPA) in the isolated plasma phospholipids. The AA/EPA ratio in the blood gives a precise insight into the balance of the precursors of pro-inflammatory eicosanoids (derived from AA) and the anti-inflammatory eicosanoids (derived from EPA) in each of the 60 trillion cells in the body. It is the balance of these eicosanoid precursors that determines the actual extent of silent inflammation in the body. Using this more sophisticated clinical marker (the AA/EPA ratio), more than 75% of Americans have high levels of silent inflammation, including millions of children.

    Silent inflammation also has important implications for the food and nutraceutical industries since upstream inflammatory potential is NOT a disease. In other words, addressing silent inflammation with products will not likely put a company's products into drug territory any more than products that address free radicals or free radical scavenging.

    The Failure of Anti-Inflammatory Drugs
    If silent inflammation is so important in accelerating chronic disease, why not simply take anti-inflammatory drugs on a lifetime basis? Anti-inflammatory drugs (aspirin, non-steroidal anti-inflammatory drugs [NSAIDs], COX-2 inhibitors, and corticosteroids) all inhibit the formation of pro-inflammatory eicosanoids. The simple answer why this approach is not fruitful is due to increased mortality. More people die each day using the correct dosage of anti-inflammatory drugs than die from AIDS. This is because anti-inflammatory drugs operate downstream by trying to inhibit the formation of pro-inflammatory eicosanoids derived from AA. Unfortunately, they function like dumb bombs in that they also inhibit the formation of anti-inflammatory eicosanoids, the end result being a constant imbalance in eicosanoid production. Chronic usage of anti-inflammatory drugs will not be the solution to the growing epidemic of silent inflammation.

    Dietary Approaches for Reducing Silent Inflammation
    It's all about balance. Put simply, AA and EPA must be at the ideal ratio in the body in order to counteract silent inflammation. It may be a matter of increasing EPA or decreasing AA with nutritional interventions and/or diet.

    One of the primary causes of silent inflammation is increased body fat. People tend to think of stored body fat as inert. Unfortunately, stored fat is a very active source of silent inflammation. Therefore, the first line of defense against silent inflammation should be the reduction of body fat because it produces an excess of the hormone insulin. As the glycemic load of the diet increases, more insulin is secreted. This in turn activates the enzyme (delta 5 desaturase), which produces AA. The same excess insulin also accelerates the storage of excess body fat in which any excess AA is deposited. As the level of AA increases in the fat cells, more inflammatory mediators such as pro-inflammatory eicosanoids and pro-inflammatory cytokines are produced. The end result is an increase in systematic inflammation that started with an increase in silent inflammation in the adipose tissue. Thus the current obesity epidemic is in reality an epidemic of silent inflammation.

    The only way to reduce excess body fat is to simultaneously reduce both insulin and calories. Of course, the secret is to do this without causing hunger. This is why low glycemic load diets, such as the Zone Diet, have been shown to be more effective than high-carbohydrate diets in reaching this goal. In fact, a recent study from Harvard Medical School has indicated that the Zone Diet is nine times more effective than the American Heart Association diet in reducing silent inflammation. In addition, recent studies conducted at Arizona State University indicate that the Atkins diet dramatically increases silent inflammation compared to the Zone Diet.

    The implications for food manufacturers is great because when the correct glycemic load is combined with the appropriate amount of protein, it is possible to produce a wide variety of anti-inflammatory foods. One of the most ambitious programs to date has been the introduction of the SmartZone nutrition bars by Hershey Foods. The ultimate commercial success of these food products will determine whether or not an entirely new category of foods that can reduce silent inflammation will emerge.

    Supplements for Silent Inflammation: A Focus on EPA and DHA
    Without doubt, the most highly medically-verified dietary supplement to reduce silent inflammation is fish oil because it is rich in the long-chain omega 3 fatty acids EPA and docosahexaenoic acid (DHA). Fish oil reduces silent inflammation by two modes of action. The first is the reduction of the formation of AA by the feedback inhibition by EPA of the enzyme (delta 5 desaturase) that produces AA. The second is the generation of extremely powerful anti-inflammatory eicosanoids from EPA and DHA known as resolvins. This is why the AA/EPA ratio is such an exceptionally powerful clinical marker in determining the extent of silent inflammation, as it measures the upstream inflammatory potential throughout the body. One standard that has been applied in clinical studies has been the use of the same AA/EPA ratio (1.5 to 3) found in the Japanese population since it has the greatest longevity, longest health span (longevity minus years of disability) and least amount of heart disease and depression in the world today. One could lower the AA/EPA even more but that might inhibit inflammatory response against infection or inhibit injury repair.

    To reach the AA/EPA ratios found in the Japanese population would require large amounts of EPA and DHA to make a significant reduction in the levels of silent inflammation. This is primarily because the standard American diet can be considered a pro-inflammatory one due to its generation of excess insulin. Some studies have indicated that in normal American subjects, approximately 2.5 grams of EPA and DHA are required on a daily basis. However, the amounts of EPA and DHA needed to reach this desired range increase with the increasing silent inflammation load in the person. For example, a person with heart disease, type 2 diabetes or obesity would require about 5 grams of EPA and DHA per day since they have significantly higher levels of silent inflammation, whereas someone with a neurological disorder such as depression, attention deficit hyperactivity disorder (ADHD), or Alzheimer's would need in excess of 10 grams of EPA and DHA per day to reduce silent inflammation as measured by the AA/EPA ratio. Thus, the amounts of EPA and DHA required are not dependent on the age, weight or gender, but rather the existing state of wellness of the person.

    The need for high doses of fish oil generates two problems. The first is the dosage form. Most fish oil capsules contain only 300 mg of EPA and DHA. Therefore to achieve an appropriate intake one would have to take an unrealistic amount of capsules. The second problem is the level of contaminants (such a mercury, PCBs and dioxins) in standard fish oils. The levels of fish oil required to significantly reduce silent inflammation would also increase the intake of these contaminants. The solution to both these obstacles occurred a few years ago with the development of ultra-refined EPA/DHA concentrates. These can be considered "weapons-grade" fish oil because they are extremely rich in EPA and DHA but extremely low in toxins. As an added benefit, the taste of these ultra-refined EPA/DHA concentrates is mild enough that the oil can now be taken as a liquid supplement thereby circumventing the problems with taking an extraordinary amount of capsules. Most of the clinical studies conducted over the past five years have used these forms of fish oil with extraordinary results. The best example was the GISSI study in which approximately 1 gram (a very low dose in my opinion) of EPA and DHA was given to heart attack survivors. After 3.5 years, those getting the fish oil had 20% less cardiovascular death and a 45% reduction in sudden cardiac death compared to the placebo group. This result indicates that low-dose ultra-refined EPA/DHA concentrates are equal to statins in reducing cardiovascular mortality and probably superior in reducing sudden cardiac death.

    There are other nutritional supplements that can also reduce the AA/EPA ratio because they are natural inhibitors of the (delta-5-desaturase) enzyme that produces AA. These include sesame lignans derived from sesame oil and cucurmin derived from turmeric. Of course, the benefits of all these supplements can be undermined by eating protein sources that are rich in AA (such as fatty red meat or egg yolks) or following a high-carbohydrate diet (which increases insulin levels that activate the delta-5-desaturase enzyme).

    And there are other anti-inflammatory supplements that act as nutritional equivalents to anti-inflammatory drugs. These supplements operate downstream by either inhibiting the enzymes (the cyclo-oxygenase {COX} or lipo-oxygenase {LOX} enzymes) that produce pro-inflammatory eicosanoids such prostaglandins like PGE2 or leukotrienes like LTB4. These supplements would include salicylic acid from willow bark, isolated glycosides from ginger and isolated polyphenols in olive oil. As time goes on, more and more natural products will be found that are inhibitors of the COX and LOX enzymes. However, these supplements might be considered drugs by the government since they use the same mechanisms of action as used by anti-inflammatory drugs. Thus, promoting their use would likely constitute a potential drug claim. Furthermore, unlike measuring the AA/EPA ratio, there is no good clinical test for demonstrating the effects of these downstream inhibitory supplements on the generation of pro-inflammatory eicosanoids other than patient testimonials.

    It should be noted that anti-inflammatory supplements are very different than antioxidants. A true anti-inflammatory supplement must either reduce the levels of precursors of pro-inflammatory eicosanoids (such as AA) or inhibit the enzymes that produce pro-inflammatory eicosanoids. As an example, vitamin E is an excellent antioxidant, but a poor anti-inflammatory supplement.

    Nutragenomics & Research
    People love trendy terms and nutragenomics is one of those. In its simplest definition, nutragenomics refers to the way nutrients interact with our genes. This relates to why silent inflammation is so insidious. The upstream inflammatory potential that represents silent inflammation provides the molecular kindling (i.e., increased AA levels) that a single match can be used to light a log (a strong and continuing inflammatory response). By simply choking off the substrate (AA) required for the production of pro-inflammatory eicosanoids, there is a significant decrease in the molecular signaling by these eicosanoids that can interact with genetic elements such as nuclear factor kappa-B to cause the transcription of a wide variety of additional inflammatory mediators, such as inducible COX-2 enzymes, and pro-inflammatory cytokines, such as interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF-alpha).

    Understanding the role of silent inflammation as the initial process in the inflammatory cascade can dramatically alter how medicine is practiced in the 21st century. It also levels the playing field. For the first time, nutrition and nutraceuticals can be clinically demonstrated to provide superior anti-inflammatory benefits (as measured by the levels of silent inflammation) compared to existing drugs because they can reduce the building blocks (AA) needed for the production of pro-inflammatory eicosanoids, while at the same time increase the levels of the building blocks (EPA) necessary for the production of anti-inflammatory eicosanoids.

    If the food and nutritional supplement industries take a true leadership role in combating silent inflammation, all of the discussions of being considered a medically validated alternative to drugs actually comes to pass. To do so, however, will require more nutraceutical companies to act like drug companies, which means they must conduct clinical trials to verify product effectiveness. There are two possible approaches that can be taken to provide the impetus to do this. The first option is to change the current model to provide new regulatory classifications for making drug claims for nutraceuticals that have met an abbreviated new drug approval, but could still be sold over the counter. This is more of a long-term approach that is not likely to come to fruition in the near future. The second approach is to have the larger companies, who are willing to do the necessary clinical trials, use the results to develop stronger relationships with the professional healthcare community to amortize their scientific investments. This approach can be done today, but it requires a commitment to product and research excellence, as well as more professional marketing programs than currently exist in the nutraceutical industry.

    Consequences of Ignoring Silent Inflammation
    Silent inflammation appears to be a major underlying cause of the development of chronic disease. Americans have the highest levels of silent inflammation in the world. Therefore, it is probably not too surprising that we spend more per capita d than any other country for healthcare, and with increasingly disappointing results. The obesity crisis is fueling this epidemic of silent inflammation, which will eventually crush our existing healthcare system. There is no drug that can reverse silent inflammation, but there are anti-inflammatory diets and anti-inflammatory dietary supplements that can.

    The actual day of reckoning will come in 2011 when the first baby boomers are able to access the substantial low cost healthcare provided by Medicare. If silent inflammation is not controlled in this group, the healthcare costs will likely bankrupt the rest of the healthcare system. Although it is highly unlikely that obesity (a primary cause of silent inflammation) will be eradicated by that time, silent inflammation can be rapidly brought under control by the use of dietary supplements that reduce AA formation. The most important of these is fish oil. The tragedy for the nutraceutical industry is that less than 1% of its sales comes from fish oil products. The sooner we recognize the growing consequences of silent inflammation, the sooner we will understand the urgency to make the necessary investments in developing nutritional approaches to help avert the coming collapse of the American healthcare system.

    About the author: Dr. Barry Sears is the president of the Inflammation Research Foundation, a non-profit organization that conducts clinical research on the dietary interventions to reverse silent inflammation. He is the author the #1 New York Times best selling book, The Zone, as well as 11 other books on his Zone Diet that have sold more than 5 million copies. His most recent book, The Anti-Inflammation Zone, discusses the impact of silent inflammation on chronic disease development. He can be reached at 781-639-1214; Fax 781-639-8154; E-mail: bsears@drsears.com; Website: www.drsears.com.

    Return to top

    Related Searches
    • Inflammation
    • Antioxidants
    • Fatty Acids
    • Bone & Joint Health
    Related Knowledge Center
    • Bone & Joint Health
    • Enzymes
    • Antioxidants
    • Fatty Acids
    • Cardiovascular Health
    • Inflammation
    • Skin Health
    • Dietary Supplements
    Suggested For You
    Antioxidants Adapt to New Growth Avenues Antioxidants Adapt to New Growth Avenues
    Omega-3s Show Benefit for Memory & Cognition Omega-3s Show Benefit for Memory & Cognition
    Qualitas Health Enters Production Partnership Qualitas Health Enters Production Partnership
    AHPA Encourages EPA to Reform Pesticide Regulations AHPA Encourages EPA to Reform Pesticide Regulations
    Nature Made Introduces Four New Supplements Nature Made Introduces Four New Supplements
    GOED Study Shows New Zealand Fish Oil Supplements Meet Label Claims GOED Study Shows New Zealand Fish Oil Supplements Meet Label Claims
    Organic & Natural Health Association Hosts Consumer Education Program Organic & Natural Health Association Hosts Consumer Education Program
    Focus on Joint Health Focus on Joint Health
    Coromega to Showcase Coromega Max and Women’s Health Omega-3 Supplements Coromega to Showcase Coromega Max and Women’s Health Omega-3 Supplements
    Coalition Forms to Fight Food Waste Coalition Forms to Fight Food Waste
    Dr. Sears Writes Book on Astaxanthin Dr. Sears Writes Book on Astaxanthin
    Getting Ahead of the Curve: Gluten-Free Getting Ahead of the Curve: Gluten-Free
    Getting Ahead of the Curve: The Gluten-Free Market Getting Ahead of the Curve: The Gluten-Free Market
    The Pharmacist’s View of Supplements
The Pharmacist’s View of Supplements
    Hidrox Effective in Promoting Joint Health Hidrox Effective in Promoting Joint Health

    Related Features

    • Antioxidants | Dietary Supplements | Energy | Eye Health | Healthy Aging | Herbs & Botanicals | Immune Function | Vitamins
      Antioxidants Adapt to New Growth Avenues

      Antioxidants Adapt to New Growth Avenues

      Brands have opportunities to reach consumers in search of general health and wellness protection, as well as those who opt for targeted solutions.
      By Sean Moloughney, Editor 03.03.21

    • Breaking News | Cognitive Function | Omega-3s | Research | Research News

      Omega-3s Show Benefit for Memory & Cognition

      Correlation found between omega-3 levels and increased blood flow in brain regions associated with memory/learning.
      05.25.17

    • Breaking News | Marine Nutraceuticals | Omega-3s | Supplier News

      Qualitas Health Enters Production Partnership

      Company signs a long-term agreement to triple algae production.
      05.25.17


    • Breaking News | Herbs & Botanicals | Regulations | Regulatory News

      AHPA Encourages EPA to Reform Pesticide Regulations

      AHPA recommended addition of nearly 200 commercially available herbal crops to Crop Group 19, ‘Herbs and Spices.’
      05.22.17

    • Cardiovascular Health | Digestive Health | Immune Function | Men's Health | Products

      Nature Made Introduces Four New Supplements

      Pharmavite brand targets heart health, immune health, digestive health, and men’s health categories.
      05.03.17

    Loading, Please Wait..
    Trending
    • Soviets Took Probiotics To The Next Level
    Breaking News
    • SmartyPants Vitamins Launches New Line of Gelatin-Free Multivitamin Gummies
    • Flavanol Deficiency Linked to Age-Related Memory Decline: COSMOS-Web Study
    • AHPA to Attend CITES Plants Committee Meeting in Geneva
    • NY General Assembly Passes Bill to Restrict Sales of Weight Loss Supplements
    • Stefan Pasiakos, PhD, Selected to Lead NIH Office of Dietary Supplements
    View Breaking News >
    CURRENT ISSUE

    June 2023

    • Functional Beverage Market Shakes Things Up with Formulation Breakthroughs
    • A Kingdom of Their Own: Fungi Shine While Mushrooms Emerge as Market Stars
    • The Pet Health Boom: Supplement Growth Set to Build on Rapid Expansion
    • (Re)Open for Business: China’s Strong Demand for Natural Products Spells Opportunity for U.S. Brands
    • Review Finds No Causative Connection Between Dietary Supplements and Eating Disorders
    • KA! Empathogenics: Creating Calm and Connectedness with Inspiration from Nature
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    SmartyPants Vitamins Launches New Line of Gelatin-Free Multivitamin Gummies
    Flavanol Deficiency Linked to Age-Related Memory Decline: COSMOS-Web Study
    AHPA to Attend CITES Plants Committee Meeting in Geneva
    Coatings World

    Latest Breaking News From Coatings World

    PPG Opens $30-Million Battery Pack Application Center in China
    Fact.MR: Steel Pipe Coatings Market To Hit $14.0 Billion By 2033
    Omya Extends Lightweight Fillers Portfolio with the Acquisition of Bublon
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Microbot receives Grant for Endovascular Surgical Robot System
    Recall of Abiomed's Impella 5.5 with SmartAssist is Class I
    New FDA Nod Boosts Philips, Masimo Partnership
    Contract Pharma

    Latest Breaking News From Contract Pharma

    KBI Biopharma Unveils KBI PUREplatform
    AGC Biologics Introduces AGCellerate to Deliver IND-Ready GMP Material
    Element Creates New Lab Solutions Division
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Fasten Wins Gold at German Innovation Awards
    Attitude Expands Oceanly Makeup Collection
    L'Oréal Leads Funding Round for Biotech Company, Debut
    Happi

    Latest Breaking News From Happi

    Skylar’s ‘Boardwalk Delight’ Eau de Parfum Launches to Record Success at Sephora
    Register for the IBA Cocktail Reception in Las Vegas During Cosmoprof North America
    Amyris Announces Transformation Program
    Ink World

    Latest Breaking News From Ink World

    DuPont Artistri Inks Expands Pigment Inks Portfolio at ITMA 2023
    Toyochem Constructs New Pilot Facility for High-Performance Polymers
    UFlex Reports Unaudited 4Q, Full Year 2023 Results
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Baldwin to exhibit 'Complete Quality Control Solutions' at High Security Printing Latin America
    Label Source acquires division of OMNI Systems
    Vetaphone demos ‘M’ corona treater at Mark Andy showroom
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Maxcess International Opens New Facility in Mumbai
    emtec Showcases Groundbreaking Achievement in Haptic Measurement
    Hollingworth & Vose Joins United Nations Global Compact initiative
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Orthonika Receives Grant for Total Meniscus Replacement
    Treace to Buy RPM-3D Tech for Up to $30 Million
    Former BD, J&J Executives Join Acuitive Technologies Board
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Schreiner Group Receives Three FINAT Awards
    MClimate Releases Maintenance-Free CO2 Display
    Blackstone Completes Acquisition of Majority Stake of Copeland

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login